PRTC
PureTech Health PLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$433.41M
P/E Ratio
9.73
EPS
$1.83
Beta
0.71
52W High
$19.92
52W Low
$14.50
50-Day MA
$16.88
200-Day MA
$17.36
Dividend Yield
—
Profit Margin
793.00%
Forward P/E
—
PEG Ratio
—
About PureTech Health PLC
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops and markets drugs for inflammatory, fibrotic and immune, intractable, lymphatic and gastrointestinal, neurological and neuropsychological cancers and other diseases in the United States. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $6.39M |
| Gross Profit (TTM) | $-48.81M |
| EBITDA | $-115.72M |
| Operating Margin | -2590.00% |
| Return on Equity | 9.44% |
| Return on Assets | -13.00% |
| Revenue/Share (TTM) | $0.27 |
| Book Value | $15.65 |
| Price-to-Book | 1.07 |
| Price-to-Sales (TTM) | 67.82 |
| EV/Revenue | 15.6 |
| EV/EBITDA | 2.54 |
| Quarterly Earnings Growth (YoY) | 61.50% |
| Quarterly Revenue Growth (YoY) | 543.00% |
| Shares Outstanding | $24.34M |
| Float | $167.37M |
| % Insiders | 0.00% |
| % Institutions | 0.39% |
Historical Volatility
HV 10-Day
55.93%
HV 20-Day
44.19%
HV 30-Day
43.42%
HV 60-Day
45.20%
HV Rank
25.8%
Volatility is currently expanding
Data last updated: 4/14/2026